Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
03/2010
03/18/2010US20100068151 Multimodality molecular imaging with therapeutic conjugates
03/18/2010US20100068150 Selective Caspase Inhibitors
03/18/2010US20100068135 Antibody compositions, methods for treating neoplastic disease and methods for regulating fertility
03/18/2010CA2737218A1 Metalloporphyrin derivatives, nanoparticles comprising the same, and use thereof for photodynamic therapy
03/18/2010CA2736732A1 Anti-cancer drugs and uses relating thereto for metastatic malignant melanoma and other cancers
03/18/2010CA2736568A1 Bidesmosidic betulin and betulinic acid derivatives and uses thereof as antitumor agents
03/18/2010CA2736488A1 Elimination of a contaminating non-human sialic acid by metabolic competition
03/18/2010CA2736370A1 Pyrazole carboxamide inhibitors of factor xa
03/18/2010CA2736295A1 Pyrrolidin-2-ones as hdm2 ligands
03/18/2010CA2735881A1 Monoclonal antibodies specific for pancreatic neoplasia cells
03/18/2010CA2734819A1 Organic compounds
03/18/2010CA2734309A1 Preparation and usage of a pharmaceutical composition containing ferulic acid and matrine compounds
03/18/2010CA2699220A1 Use of a peptide as a therapeutic agent
03/17/2010EP2163643A1 Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof
03/17/2010EP2163626A1 Human FGF-21 gene and gene expression products
03/17/2010EP2163564A1 Cancerous disease modifying antibodies
03/17/2010EP2163557A1 Function-selective vitamin d receptor agonist
03/17/2010EP2163552A1 Indole derivatives and their use as antitumor agents
03/17/2010EP2163546A1 Quinazoline derivatives
03/17/2010EP2163258A1 Preventive/remedy for cancer
03/17/2010EP2163256A1 Specific binding proteins and uses thereof
03/17/2010EP2163250A1 Anticancer therapy by transplanting vascular endothelial progenitor cells
03/17/2010EP2163247A1 USE OF NARINGENIN AND NARINGIN AS INHIBITORS FOR TRANSFORMING GROWTH FACTOR-beta1 SIGNALING PATHWAY
03/17/2010EP2162534A1 Cd34 stem cell-related methods and compositions
03/17/2010EP2162471A1 Compositions and methods for treating pancreatic tumors
03/17/2010EP2162458A1 Protein kinase-binding nucleosides and associated methods
03/17/2010EP2162454A1 Imidazopyridine kinase inhibitors
03/17/2010EP2162445A1 Heterobicyclic compounds as kinase inhibitors
03/17/2010EP2162443A2 Heteroarylamide-substituted pyrimidone derivatives for the treatment of neurodegenerative diseases
03/17/2010EP2162190A1 Biphenylcarboxamide derivatives as hedgehog pathway modulators
03/17/2010EP2162156A2 Immunocytokines for cancer treatment in combination with chemotherapeutic agents
03/17/2010EP2162129A1 Use of hdac inhibitors for the treatment of bone destruction
03/17/2010EP2162128A1 Sesquiterpene formulations, kits and methods of use thereof
03/17/2010EP2162123A1 Honokiol analogs and their use in treating cancers
03/17/2010EP1933945B1 A pharmaceutical composition comprising mahanine useful for the treatment of prostate cancer
03/17/2010EP1654257B1 Aminopyrones and their use as atm inhibitors
03/17/2010EP1620411B1 Inhibitors of akt activity
03/17/2010EP1490098B1 Chemotherapeutic agents as anti-cancer vaccine adjuvants and therapeutic methods thereof
03/17/2010EP1315502B1 Method for treating erectile dysfunction and increasing libido in men
03/17/2010CN101675158A Cancerous disease modifying antibodies
03/17/2010CN101675054A Cyclopamine lactam analogs and methods of use thereof
03/17/2010CN101675053A Phosphoinositide 3-kinase inhibitor compounds and methods of use
03/17/2010CN101675051A Pyrazolopyrimidine analogs and their use as mtor kinase and pi3 kinase inhibitors
03/17/2010CN101675033A Aryl pyridyl sulfonamide derivatives, their manufacture and use as pharmaceutical agents
03/17/2010CN101674852A Multi-functional polyglutamate drug carriers
03/17/2010CN101674846A Antibodies against erbb3 and uses thereof
03/17/2010CN101674838A Compositions and methods for treating cancer
03/17/2010CN101674834A inhibitors of bruton's tyrosine kinase
03/17/2010CN101674828A Raf inhibitors for the treatment of thyroid cancer
03/17/2010CN101674820A Method of using histone deacetylase inhibitors and monitoring biomarkers in combination therapy
03/17/2010CN101674810A Targeting agent for cancer cell or cancer-associated fibroblast
03/17/2010CN101671670A Hepatocellular carcinoma targeting gene expression element AP and applications thereof
03/17/2010CN101671669A Hepatocellular carcinoma targeting gene expression element AE and applications thereof
03/17/2010CN101671668A Hepatocellular carcinoma targeting gene expression element AG and applications thereof
03/17/2010CN101671666A Proliferation and tumor cell specific gene operating system for gene therapy of malignant tumor
03/17/2010CN101671656A Method for targeting and killing prostate tumor cells by oncolytic I type herpes simplex viruses
03/17/2010CN101671638A New strain of bifidobacterium and fermentative preparation method and application thereof
03/17/2010CN101671397A Anti-EGFR single-chain antibody fusion Gelonin recombination immunotoxin, preparation method and usage thereof
03/17/2010CN101671393A Angiopoietin-2 specific binding agents
03/17/2010CN101671390A Human interferon alpha derivatives and preparation and use of pegylated products thereof
03/17/2010CN101671387A Trichinella spiralis and tumor cell associated antigen protein and preparation method and medical application thereof
03/17/2010CN101671382A Ultra-micronized megestrol acetate and pharmaceutical composition containing same
03/17/2010CN101671376A Alkannin acetyl glucose and preparation method and application thereof
03/17/2010CN101671369A Phosphoryl methyl salinomycin ether derivative and preparation method thereof
03/17/2010CN101671335A Cytotoxins, prodrugs, linkers and stabilizers useful therefor
03/17/2010CN101671329A Indolylmaleimide compound substituted with 3-amino alcohol, preparation method and application thereof
03/17/2010CN101671319A Taxus nontoxic extract process
03/17/2010CN101671299A Method for synthesizing Nexavar
03/17/2010CN101671278A Carbamic acid alkannin ester as well as preparation method and application thereof
03/17/2010CN101671248A Long effective curcumin derivative and preparation method thereof
03/17/2010CN101670116A Forebody drug with conjugate linoleic acid connected with antitumor drug and preparation method thereof
03/17/2010CN101670115A Compound of heparanase and heat shock protein, preparation method and applications thereof
03/17/2010CN101670114A Compound of survivin and heat shock protein, preparation method and applications thereof
03/17/2010CN101670112A Stable albumins lipid medicine carrying system and preparation method thereof
03/17/2010CN101670108A Medicine carrying system based on nano graphene oxide
03/17/2010CN101670102A Method for combining poxvirus vector HIV vaccine and adenoviral vector HIV vaccine and application
03/17/2010CN101670100A Tolerogenic tumor-cell antigen-loaded dendritic cell, preparation method and application thereof
03/17/2010CN101670095A Pharmaceutical composition for treating embolism and preparation method thereof
03/17/2010CN101670090A Pharmaceutical composition for treating intermediate and advanced malignant tumors and preparation method thereof
03/17/2010CN101670079A Chinese medicament for treating chronic atrophic gastritis, preventing and treating gastric cancer
03/17/2010CN101670073A Traditional Chinese medicine composite for treating damp-heat pattern oesophageal carcinoma
03/17/2010CN101670071A Traditional Chinese medicine preparation for treating cancer and preparation method thereof
03/17/2010CN101670056A Medicament for treating malignant tumor
03/17/2010CN101670045A Externally applied traditional Chinese medicine for treating cervical carcinoma
03/17/2010CN101670034A Application of traditional Chinese drug Zengshengping to treating mammary gland tumor
03/17/2010CN101670028A Traditional Chinese medicine composite for treating cold-dampness pattern oesophageal carcinoma
03/17/2010CN101670025A Ginseng cancer recovery medicinal powder
03/17/2010CN101670018A Method for preparing camellia saponin controlled-release tablets
03/17/2010CN101670010A Method for extracting flavonoid glycoside substance
03/17/2010CN101669998A Corydalis saxicola pill and preparation method thereof
03/17/2010CN101669981A Method for extracting hydroxyl naphthoquinone total pigment with supercritical carbon dioxide
03/17/2010CN101669973A Biological immunopotentiator composition for treating cancers
03/17/2010CN101669972A Preparation method of capsules for treating breast cancer
03/17/2010CN101669971A Compound extracted from shark cartilage marrows
03/17/2010CN101669970A Method for microwave extracting fat-soluble toad venom by using skin of Bufo bufo gargarizans
03/17/2010CN101669958A Pharmaceutical uses of bisphosphonates
03/17/2010CN101669951A Novel application of substituted piperazinphenylisoxazoline derivative in preparation of anti-tumor medicament
03/17/2010CN101669945A Joint synergy of ferulic acid and matrine alkaloid and medical application thereof
03/17/2010CN101669942A Insoluble pharmaceutical composition
03/17/2010CN101669941A Method for treating malignant tumors with joint medicament administration and anti-malignant tumor medicament
1 ... 715 716 717 718 719 720 721 722 723 724 725 726 727 728 729 730 731 732 733 734 735 ... 2211